SCHEMBL18267652

SCHEMBL18267652

c1ccc(-c2ccc(N(c3ccc(-c4ccc5c(ccc6ccc7c8ccccc8oc7c65)c4)cc3)c3cccc(-c4ccccc4)c3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.36
▸ PGR P06401 1/20 0.35
▸ PLA2G2A P14555 3/20 0.34
▸ PLA2G4A P47712 3/20 0.34
▸ CYP1A2 P05177 3/20 0.34
▸ CYP1A1 P04798 2/20 0.34
▸ CYP1B1 Q16678 1/20 0.34
▸ HCRTR1 O43613 1/20 0.33
▸ CYP19A1 P11511 1/20 0.33
▸ PLA2G10 O15496 1/20 0.33
▸ GPR84 Q9NQS5 1/20 0.33
▸ AHR P35869 2/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ JAK2 O60674 1/20 0.32
▸ ZAP70 P43403 1/20 0.32
▸ SYK P43405 1/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18267659 1.00 ALOX5 (0.36) ALOX5PGRPLA2G2APLA2G4ACYP1A2
SCHEMBL18267555 0.98 ALOX5 (0.36) ALOX5PGRPLA2G2APLA2G4ACYP1A2
SCHEMBL18267655 0.96 ALOX5 (0.37) ALOX5PGRPLA2G2APLA2G4ACYP1A2
SCHEMBL18267656 0.96 ALOX5 (0.34) ALOX5PLA2G2APLA2G4ACYP1A2CYP1A1
SCHEMBL18267678 0.96 PGR (0.37) ALOX5PGRPLA2G2APLA2G4ACYP1A2
SCHEMBL18267705 0.95 PLA2G2A (0.37) ALOX5PGRPLA2G2APLA2G4ACYP1A2
SCHEMBL18267657 0.95 PGR (0.38) ALOX5PGRPLA2G2APLA2G4ACYP1A2
SCHEMBL18267704 0.94 PLA2G2A (0.38) ALOX5PGRPLA2G2APLA2G4ACYP1A2
SCHEMBL18267566 0.94 PGR (0.35) ALOX5PGRPLA2G2APLA2G4ACYP1A2
SCHEMBL18267556 0.94 PLA2G2A (0.38) ALOX5PGRPLA2G2APLA2G4ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446760-B2 Organic compound, organic optoelectric diode, and display device SAMSUNG SDI CO., LTD. (KR) 2019-10-15 — — US disclosed
US-20160351820-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRIC DIODE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-12-01 — — US disclosed
US-20160351820-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRIC DIODE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-12-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10446760-B2 Organic compound, organic optoelectric diode, and display device OCIAD1, OXER1, OR10J3 ALOX5 527/4885PGR 2546/4885PLA2G2A 4691/4885
US-20160351820-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRIC DIODE, AND DISPLAY DEVICE OCIAD1, OXER1, OR10J3 ALOX5 527/4885PGR 2546/4885PLA2G2A 4691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback